BioSenic S.A. (EBR:BIOS)
Belgium flag Belgium · Delayed Price · Currency is EUR
0.0020
0.00 (0.00%)
May 26, 2026, 10:35 AM CET

BioSenic Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-2.390.10.340.30.31
Revenue Growth
--69.64%13.51%-5.13%-
Gross Profit
-2.390.10.340.30.31
Operating Income
-5.14-5.21-23.13-2.32-0.88
Net Income
-4-4.77-28.78-2.04-0.98
Earnings Per Share
-0.01-0.02-0.21-0.02-14.89
EPS Growth
-----

Cash & Debt

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.50.390.121.850.76
Total Debt
23.5327.7328.1623.793.53
Net Cash (Debt)
-23.03-27.34-28.04-21.94-2.77
Net Cash Growth
-----
Net Cash Per Share
-0.05-0.12-0.20-0.18-41.86

Cash Flow & CapEx

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-1.82-2.22-3.47-1.91-1.07
Capital Expenditures
----0.01-
Free Cash Flow
-1.82-2.22-3.47-1.92-1.07
Free Cash Flow Growth
-----

Margins

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-100.00%100.00%100.00%100.00%
Operating Margin
--5103.92%-6884.82%-783.11%-281.09%
Pretax Margin
248.76%-6578.43%-8639.29%-1030.07%-315.38%
Profit Margin
--4674.51%-8564.88%-689.53%-315.38%
FCF Margin
--2177.45%-1032.74%-646.96%-341.99%

Valuation

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-3.173.17--
PS Ratio
-0.5518.4229.7210.13-